Profound Medical Announces Non-Brokered Private Placement
January 16, 2024 16:30 ET
|
Profound Medical Corp.
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) ("Profound" or the "Company") is pleased to announce that the Company has entered into subscription...
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
January 03, 2024 16:15 ET
|
Profound Medical Corp.
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
December 27, 2023 22:40 ET
|
Profound Medical Corp.
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) today announced the pricing of its previously announced underwritten public...
Profound Medical Announces Proposed Public Offering of Common Shares
December 27, 2023 16:15 ET
|
Profound Medical Corp.
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce the commencement of an underwritten public offering in...
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
November 08, 2023 07:45 ET
|
Profound Medical Corp.
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
November 03, 2023 08:00 ET
|
Profound Medical Corp.
TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Third Quarter 2023 Financial Results
November 02, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
October 19, 2023 16:30 ET
|
Profound Medical Corp.
TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
October 10, 2023 16:30 ET
|
Profound Medical Corp.
TORONTO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
September 25, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...